Dr. Wally Curran

Global Chief Medical Officer

Dr. Walter (Wally)  J. Curran, Jr., is Professor Emeritus and former Chairman of the Department of Radiation Oncology at Emory University School of Medicine. He joined GenesisCare as the Group Chief Medical Officer in January 2021.

Wally served for 11 years as the Executive Director of Winship Cancer Institute of Emory University, the first and only National Cancer Institute (NCI)-designated Comprehensive Cancer Center in the state of Georgia, USA. He was the first radiation oncologist to serve as a director of an NCI-designated cancer center.

Wally is considered an international expert in the management of patients with locally advanced lung cancer and malignant brain tumors  led several landmark clinical and translational trials in both areas, and isresponsible for defining a universally adopted staging system for patients with malignant glioma.

Wally served as the group chairman and principal investigator of NRG Oncology for eight years and the Radiation Therapy Oncology Group (RTOG) for seventeen years. Both are NCI-funded cooperative groups dedicated to advancing patient treatment and care through clinical trials and research.

Wally has authored or co-authored more than 800 abstracts and scholarly papers, as well as numerous presentations, reviews, and book chapters. He has been chairman or co-chairman of more than 40 clinical trials and a reviewer for 12 national/international journals.

Wally is a Fellow and served on the Board of Directors of the American Society of Clinical Oncology (ASCO). He was also named a Georgia Research Alliance Eminent Scholar and Chair in Cancer Research in 2013. He served as the founding secretary/treasurer of the Coalition of Cancer Cooperative Groups and a Board member of the Georgia Center for Oncology Research and Education (Georgia CORE).

He is also a Fellow in the American College of Radiology,has been awarded honorary memberships in the European Society of Therapeutic Radiology and Oncology and the Canadian Association of Radiation Oncology, and received the Gold Medal Award from the American Society of Radiation Oncology (ASTRO) in 2019

Prior to joining Emory University, Wally was Professor and Chairman of Radiation Oncology at Thomas Jefferson University in Philadelphia and Clinical Director of Jefferson’s Kimmel Cancer Center.

Michelle Wilson

Michelle Wilson MBChB, MD, FRACP is a Staff Medical Oncologist at the Auckland City Hospital and clinical director for Cancer and Blood Research at Auckland Hospital. She is the co-chair for the NZ Cancer Teletrials steering committee. Her research focus is geared towards early phase translational studies, the relevance of genetic testing in oncology and clinical trials endpoints; in particular, their utility and evolution in an era of precision oncology practice. She was awarded an MD from the University of Auckland for her work on the challenges facing clinical trial design in oncology. She is an active member of the research advisory committee for the Australia New Zealand Gynaeoncology Group (ANZGOG) and ISOQOL. She prides herself on patient-centred care and increasing research opportunities for patients facing a diagnosis of cancer in NZ.

Madhavi Chilkuri

Radiation Oncologist, Townsville Cancer Centre
Senior Lecturer, James Cook University

Having trained at Tata memorial Hospital in India and subsequent clinical practice in India, Jamaica and regional Australia, Madhavi is currently working at Townsville University Hospital and involved in clinical research and capacity building. She is a passionate advocate for a stable and supported regional work force and research partnerships to bring optimal cancer care and cutting-edge clinical research to regional, rural and First Nations people. As an immediate past board member of RANZCR and TROG, Madhavi was involved in overseeing the Research Strategy of both organisations. Her greatest joy these days comes from mentoring and partnering with medical students and junior doctors in conducting research and writing publications.

ASM Countdown

Important Dates

Abstract Presenter Registration Deadline

24 April 2022

Early Bird Registration Closes

8 May 2022

Attendance Grant Submissions close

8 May 2022